Lena E Winestone1, Lauren L Hochman2, James E Sharpe2, Elysia Alvarez3, Laura Becker4, Eric J Chow5, Joseph G Reiter2, Jill P Ginsberg6,7, Jeffrey H Silber2,6,8. 1. Division of Allergy, Immunology, and Blood & Marrow Transplant, Department of Pediatrics, University of California San Francisco (UCSF) Benioff Children's Hospital; and UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. 2. Center for Outcomes Research, Children's Hospital of Philadelphia, Philadelphia, PA. 3. Department of Pediatrics, University of California Davis, Sacramento, CA. 4. OptumLabs, Cambridge, MA. 5. Department of Pediatrics, University of Washington, Seattle Children's Hospital; and Fred Hutchinson Cancer Research Institute, Seattle, WA. 6. Department of Pediatrics, University of Pennsylvania Perelman School of Medicine; and Division of Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA. 7. Cancer Survivorship Program, Children's Hospital of Philadelphia, Philadelphia, PA. 8. Department of Health Care Management, The Wharton School; and Leonard Davis Institute of Health Economics, The University of Pennsylvania, Philadelphia, PA.
Abstract
PURPOSE: The 2010 Dependent Coverage Provision (DCP) of the Affordable Care Act (ACA) allowed enrollees to remain on their parents' health insurance until 26 years of age. We compared rates of insurance disenrollment among patients with cancer who were DCP-eligible at age 19 to those who were not eligible at age 19. METHODS: Using OptumLabs Data Warehouse, which contains longitudinal, real-world, de-identified administrative claims for commercial enrollees, we examined patients born between 1982 and 1993 and diagnosed with cancer between 2000 and 2015. In the recent cohort, patients who turned 19 in 2010-2012 (DCP-eligible to stay on parents' insurance) were matched to patients who turned 19 in 2007-2009 (not DCP-eligible when turning 19). In an earlier control cohort, patients who turned 19 between 2004 and 2006 (not DCP-eligible) were matched to patients who turned 19 between 2001 and 2003 (not DCP-eligible). Patients were matched on cancer type, diagnosis date, demographics, and treatment characteristics. The time to loss of coverage was estimated using Cox models. Difference-in-difference between the recent and earlier cohorts was also evaluated. RESULTS: A total of 2,829 patients who turned 19 years of age in 2010-2012 were matched to patients who turned 19 in 2007-2009. Median time to disenrollment was 26 months for younger patients versus 22 months for older patients (hazard ratio [HR], 0.85; 95% CI, 0.80 to 0.90; P = .001). In 8,978 patients who turned 19 between 2001 and 2006, median time to disenrollment was 20 months among both younger and older patients (HR, 0.99; 95% CI, 0.94 to 1.03; P = .59). The difference between the recent cohort and the earlier control cohort was a 15% greater reduction in coverage loss (P < .0001), favoring those turning 19 after the DCP went into effect. CONCLUSION: In the vulnerable population of adolescent and young adult cancer survivors, the ACA may have lowered the insurance dropout rate.
PURPOSE: The 2010 Dependent Coverage Provision (DCP) of the Affordable Care Act (ACA) allowed enrollees to remain on their parents' health insurance until 26 years of age. We compared rates of insurance disenrollment among patients with cancer who were DCP-eligible at age 19 to those who were not eligible at age 19. METHODS: Using OptumLabs Data Warehouse, which contains longitudinal, real-world, de-identified administrative claims for commercial enrollees, we examined patients born between 1982 and 1993 and diagnosed with cancer between 2000 and 2015. In the recent cohort, patients who turned 19 in 2010-2012 (DCP-eligible to stay on parents' insurance) were matched to patients who turned 19 in 2007-2009 (not DCP-eligible when turning 19). In an earlier control cohort, patients who turned 19 between 2004 and 2006 (not DCP-eligible) were matched to patients who turned 19 between 2001 and 2003 (not DCP-eligible). Patients were matched on cancer type, diagnosis date, demographics, and treatment characteristics. The time to loss of coverage was estimated using Cox models. Difference-in-difference between the recent and earlier cohorts was also evaluated. RESULTS: A total of 2,829 patients who turned 19 years of age in 2010-2012 were matched to patients who turned 19 in 2007-2009. Median time to disenrollment was 26 months for younger patients versus 22 months for older patients (hazard ratio [HR], 0.85; 95% CI, 0.80 to 0.90; P = .001). In 8,978 patients who turned 19 between 2001 and 2006, median time to disenrollment was 20 months among both younger and older patients (HR, 0.99; 95% CI, 0.94 to 1.03; P = .59). The difference between the recent cohort and the earlier control cohort was a 15% greater reduction in coverage loss (P < .0001), favoring those turning 19 after the DCP went into effect. CONCLUSION: In the vulnerable population of adolescent and young adult cancer survivors, the ACA may have lowered the insurance dropout rate.
Authors: Anthony S Robbins; Xuesong Han; Elizabeth M Ward; Edgar P Simard; Zhiyuan Zheng; Ahmedin Jemal Journal: JAMA Date: 2015-11-24 Impact factor: 56.272
Authors: John W Scott; Benjamin D Sommers; Thomas C Tsai; Kirstin W Scott; Aaron L Schwartz; Zirui Song Journal: Health Aff (Millwood) Date: 2015-01 Impact factor: 6.301
Authors: Elyse R Park; Anne C Kirchhoff; Ryan D Nipp; Karen Donelan; Wendy M Leisenring; Gregory T Armstrong; Karen A Kuhlthau Journal: JAMA Intern Med Date: 2017-12-01 Impact factor: 21.873
Authors: Allison G Close; Alexandra Dreyzin; Kimberly D Miller; Brittani K N Seynnaeve; Louis B Rapkin Journal: CA Cancer J Clin Date: 2019-10-08 Impact factor: 508.702
Authors: Benjamin D Sommers; Thomas Buchmueller; Sandra L Decker; Colleen Carey; Richard Kronick Journal: Health Aff (Millwood) Date: 2012-12-19 Impact factor: 6.301
Authors: Paul J Wallace; Nilay D Shah; Taylor Dennen; Paul A Bleicher; Paul D Bleicher; William H Crown Journal: Health Aff (Millwood) Date: 2014-07 Impact factor: 6.301
Authors: Justine M Kahn; Frances B Maguire; Qian Li; Renata Abrahão; Jamie E Flerlage; Elysia Alvarez; Theresa H M Keegan Journal: Cancer Date: 2021-09-08 Impact factor: 6.860
Authors: Michael Roth; Amy Berkman; Clark R Andersen; Branko Cuglievan; J Andrew Livingston; Michelle Hildebrandt; Archie Bleyer Journal: Oncologist Date: 2022-03-04 Impact factor: 5.837